Split-thickness Skin Graft Donor Sites Clinical Trial
Official title:
Split-Thickness Skin Graft Donor Site Wound Healing Study
The purpose of this research study is to discover whether instruments widely used in skin research can be used to measure wound healing in split thickness skin graft donor sites and whether these instruments can detect differences in healing when two different dressing products are used.
Currently there is no standard treatment to promote wound healing for split thickness skin graft donor sites and healing is determined based on clinical observation of the graft donor site and clinical judgement. Here we propose to use two instruments commonly used in skin research to measure wound healing. This study will validate the use of these two instruments, one that measures transepidermal water loss and the other that measures skin pigmentation to determine healing. To further validate the use of these instruments we will determine if these instruments can detect differences between two different wound dressing products that have been previously reported to heal skin graft donor sites at different rates. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01512017 -
Clinical Study on Veloderm for the Treatment of Split-thickness Skin Graft Donor Sites
|
Phase 3 | |
| Withdrawn |
NCT02712164 -
Molecular, Histologic, and Clinical Analysis of Negative Pressure Wound Therapy (NPWT) for Split-thickness Skin Graft (STSG) Donor Sites
|
N/A | |
| Completed |
NCT02642679 -
Evaluation of Opticell Ag on Split-Thickness Skin Graft Donor Sites in Adult Subjects
|
N/A |